BCAB - CIK 0001826892
The table below shows BioAtla, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $7.12M | $49.05M | $111.47M | $215.51M | $244.98M |
| Short-term investments | - | - | - | - | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $8.01M | $51.23M | $116.41M | $220.43M | $247.29M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment |
| $120.00K |
| $678.00K |
| $1.60M |
| $2.73M |
| $3.68M |
| Goodwill | - | - | - | - | - |
| Total assets | $13.83M | $52.42M | $119.66M | $225.74M | $254.42M |
| Accounts payable | $8.19M | $1.90M | $3.82M | $4.23M | $1.18M |
| Total current liabilities | $21.92M | $14.54M | $28.34M | $23.13M | $19.81M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $50.02M | $38.16M | $48.99M | $45.40M | $43.60M |
| Retained earnings | -$545.65M | -$486.04M | -$416.26M | -$292.80M | -$186.32M |
| Total equity | -$36.19M | $14.27M | $70.67M | $180.34M | $210.82M |